GIFLF:OTCMKTS
Grifols SA Class A
11,13Â $
0,00%
(0,00) 1 p
15. sept, 15:11:14 GMT −4 · USD
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse GIFLF põhistatistika genereerimine…
Turu kapit.
6,68Â mld
Keskm. maht
543,00
Maht
0,00
52 näd kõrgeim
12,90Â $
52 näd madalaim
10,13Â $
Beeta
0,90
Käibivad aktsiad
426,13Â mln
Töötajate arv
25Â tuh
Turu kapit.
6,68Â mld
Keskm. maht
543,00
Maht
0,00
52 näd kõrgeim
12,90Â $
52 näd madalaim
10,13Â $
Beeta
0,90
Käibivad aktsiad
426,13Â mln
Töötajate arv
25Â tuh
Uudised
Veebiallikatest ja uudistepartneritelt
AD HOC NEWS
·
1 tunni eest
Grifols stock was upgraded as first-half profit rose
AD HOC NEWS
·
5 tunni eest
Grifols stock pre-market: EUR 9.84, prior close EUR 9.87
Yahoo Finance
·
22 tunni eest
Are Options Traders Betting on a Big Move in Grifols Stock?
AD HOC NEWS
·
23 tunni eest
Grifols stock reports stronger first half with profit up 28.7%
Profiil
Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over 30.
Principally a producer of blood plasma–based products and other biopharmaceuticals, the company also operates in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, as well as clinical diagnostic technologies. Furthermore, it provides biological supplies for life-science research, clinical trials and the manufacturing of pharmaceutical and diagnostic products. It has a portfolio on four therapeutic areas: immunology, infectious diseases, pulmonology and critical care. Wikipedia
Teave üksuse Grifols SA Class A kohta